The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis
Authors:
- Dang The HungDHDang The Hung
- Linh TranLTLinh Tran
- Dao Ngoc Hien TamDTDao Ngoc Hien Tam
- Ghada ElshafeiGEGhada Elshafei
- Nguyen The Ky CuongNCNguyen The Ky Cuong
- Nam Xuan HaNHNam Xuan Ha
- Sarah Abd Elaziz KhaderSKSarah Abd Elaziz Khader
- Loc Le QuangLQLoc Le Quang
- Hosam Waleed ShaikhkhalilHSHosam Waleed Shaikhkhalil
- Abdallfatah AbdallfatahAAAbdallfatah Abdallfatah
- Jeza M Abdul AzizJeza M Abdul Aziz
- Kenji HirayamaKHKenji Hirayama
- 14 May 2024
- journal article
- research article
- Published by Springer Nature in Parasitology Research
- Vol. 123 (5) , 1-8
Abstract
Artemisinin (ART) combination therapy is the main treatment for malaria. Pfk13 mutations (or K13 mutations, Kelch 13) are associated with ART resistance. This study aims to conduct a systematic review and meta-analysis of the prevalence of K13 mutations with ART resistance in malaria-endemic countries. An electronic search of studies in 2018 and a manual search in 2020 were performed to identify relevant studies. The risk of bias was assessed using the National Institutes of Health (NIH) quality assessment tool for observational cohort and cross-sectional studies. Data analysis was performed using R 4.1.0. Heterogeneity was estimated using the statistic I2 and Cochran Q test. A total of 170 studies were included in our review. Of these, 55 studies investigated the prevalence of K13 mutations in Southeast Asia. The meta-analysis showed that Southeast Asia had the highest prevalence of K13 mutations, whereas Africa, South America, Oceania, and other Asian countries outside Southeast Asia had a low prevalence of K13 mutations. The C580Y mutation was the most common in Southeast Asia with 35.5% (95%CI: 25.4–46.4%), whereas the dominant mutation in Africa was K189T (22.8%, 95%CI: 7.6–43.2%). This study revealed the emergence of ART resistance associated with K13 mutations in Southeast Asia. The diversity of each type of K13 mutation in other regions was also reported.Keywords
This publication has 31 references indexed in Scilit:
- Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survivalNature Communications, 2021
- Efficacy and resistance of different artemisinin-based combination therapies: a systematic review and network meta-analysisParasitology International, 2020
- How to perform a meta-analysis with R: a practical tutorialEvidence Based Mental Health, 2019
- K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factorsMalaria Journal, 2019
- Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province, China from AfricaBMC Infectious Diseases, 2017
- Evaluating malaria case management at public health facilities in two provinces in AngolaMalaria Journal, 2017
- The threat of artemisinin resistant malaria in Southeast AsiaTravel Medicine and Infectious Disease, 2016
- Manual search approaches used by systematic reviewers in dermatologyJournal of the Medical Library Association, 2016
- A molecular marker of artemisinin-resistant Plasmodium falciparum malariaNature, 2013
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009